Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Braz. j. microbiol ; 46(3): 885-892, July-Sept. 2015. tab, ilus
Article in English | LILACS | ID: lil-755834

ABSTRACT

This study was conducted to determine the species distribution, antimicrobial resistance pheno- and genotypes and virulence traits of mannitol-positive methicillin-resistant staphylococci (MRS) isolated from pigs in Nsukka agricultural zone, Nigeria. Twenty mannitol-positive methicillin-resistant coagulase-negative staphylococcal (MRCoNS) strains harboring the mecA gene were detected among the 64 Staphylococcus isolates from 291 pigs. A total of 4 species were identified among the MRCoNS isolates, namely, Staphylococcus sciuri (10 strains), Staphylococcus lentus (6 strains), Staphylococcus cohnii (3 strains) and Staphylococcus haemolyticus (one strain). All MRCoNS isolates were multidrug-resistant. In addition to β-lactams, the strains were resistant to fusidic acid (85%), tetracycline (75%), streptomycin (65%), ciprofloxacin (65%), and trimethoprim/sulphamethoxazole (60%). In addition to the mecA and blaZ genes, other antimicrobial resistance genes detected were tet(K), tet(M), tet(L), erm(B), erm(C), aacA-aphD, aphA3, str, dfrK, dfrG, catpC221, and catpC223. Thirteen isolates were found to be ciprofloxacin-resistant, and all harbored a Ser84Leu mutation within the QRDR of the GyrA protein, with 3 isolates showing 2 extra substitutions, Ser98Ile and Arg100Lys (one strain) and Glu88Asp and Asp96Thr (2 strains). A phylogenetic tree of the QRDR nucleotide sequences in the gyrA gene revealed a high nucleotide diversity, with several major clusters not associated with the bacterial species. Our study highlights the possibility of transfer of mecA ...


Subject(s)
Animals , Drug Resistance, Multiple, Bacterial/genetics , Fermentation/physiology , Mannitol/metabolism , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Methicillin-Resistant Staphylococcus aureus/metabolism , Staphylococcus haemolyticus/isolation & purification , Staphylococcus haemolyticus/metabolism , Anti-Bacterial Agents/pharmacology , Bacterial Proteins/genetics , DNA Gyrase/genetics , DNA, Bacterial/genetics , Genes, Bacterial/genetics , Microbial Sensitivity Tests , Methicillin-Resistant Staphylococcus aureus/genetics , Methicillin-Resistant Staphylococcus aureus/pathogenicity , Nigeria , Penicillin-Binding Proteins/genetics , Staphylococcal Infections/microbiology , Staphylococcus haemolyticus/genetics , Staphylococcus haemolyticus/pathogenicity , Swine/microbiology
2.
Braz. j. microbiol ; 46(2): 531-533, Apr-Jun/2015. tab
Article in English | LILACS | ID: lil-749720

ABSTRACT

The isolation of mannitol-negative methicillin-resistant Staphylococcus aureus from nasal swabs is reported. Among the 59 isolates, 9 (15%) isolates were mannitol-negative; all of these isolates were categorized as staphylococcal cassette chromosome mec (SCCmec) type IVa. This report emphasizes that mannitol fermentation on mannitol salt agar should not be used as the sole criterion when screening nasal swab specimens for S. aureus.


Subject(s)
Humans , Mannitol/metabolism , Methicillin-Resistant Staphylococcus aureus/isolation & purification , Methicillin-Resistant Staphylococcus aureus/metabolism , Nasal Mucosa/microbiology , Brazil , DNA, Bacterial/genetics , Fermentation , Genetic Loci , Methicillin-Resistant Staphylococcus aureus/classification
3.
Yonsei Medical Journal ; : 901-911, 2010.
Article in English | WPRIM | ID: wpr-33812

ABSTRACT

PURPOSE: Antimicrobial resistance monitoring could be a useful source of information for treating and controlling nosocomial infections. We analyzed antimicrobial resistance data generated by Korean Hospitals and by a commercial laboratory in 2005 and 2007. MATERIALS AND METHODS: Susceptibility data for 2005 and 2007 were collected from 37 and 41 hospitals, respectively, and from one commercial laboratory. Intermediate susceptibility was not included in the calculation of resistance rates. RESULTS: Methicillin-resistant Staphylococcus aureus (MRSA) (64%), third-generation cephalosporin-resistant Klebsiella pneumoniae (29%), fluoroquinolone-resistant Escherichia coli (27%), Pseudomonas aeruginosa (33%), and Acinetobacter spp. (48%), and amikacin-resistant P. aeruginosa (19%) and Acinetobacter spp. (37%) were prevalent in hospitals in 2007. A gradual increase of vancomycin-resistant Enterococcus faecium and imipenem-resistant Acinetobacter spp. was observed. Higher incidences of third-generation cephalosporin-resistant E. coli and K. pneumoniae and imipenem-resistant P. aeruginosa were found in the commercial laboratory than in the hospitals. CONCLUSION: Methicillin-resistant S. aureus, third-generation cephalosporin-resistant K. pneumoniae, and fluoroquinolone-resistant E. coli, P. aeruginosa and Acinetobacter spp. remain prevalent in Korea, while the incidence of vancomycin-resistant E. faecium and imipenem-resistant Acinetobacter spp. has increased gradually. The higher prevalences of third-generation cephalosporin-resistant E. coli and K. pneumoniae, and imipenem-resistant P. aeruginosa in the commercial laboratory are a new concern.


Subject(s)
Humans , Acinetobacter/metabolism , Bacterial Infections/drug therapy , Ceftazidime/pharmacology , Cross Infection/drug therapy , Drug Resistance, Bacterial , Escherichia coli/metabolism , Fluoroquinolones/pharmacology , Imipenem/pharmacology , Klebsiella Infections/drug therapy , Klebsiella pneumoniae/metabolism , Methicillin-Resistant Staphylococcus aureus/metabolism , Pseudomonas aeruginosa/metabolism , Republic of Korea , Vancomycin/pharmacology
SELECTION OF CITATIONS
SEARCH DETAIL